Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Pediatrics|June 1, 2016
Risk of Suicidal Events With Atomoxetine Compared to Stimulant Treatment: A Cohort StudyStephan Linden, Regina Bussing, Paul Kubilis, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 25, 2003
Nature of preventable adverse drug events in hospitals: a literature reviewPenkarn Kanjanarat, Almut G Winterstein, Thomas E Johns, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2015
Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guidesChih-Ying Chen, Regina Bussing, Abraham G Hartzema, et al.
Journal of the American Pharmacists Association : Japha|September 18, 2020
Using a pharmacist-community health worker collaboration to address medication adherence barriersLeah Wheat, Teresa E Roane, Amber Connelly, et al.
Social Science & Medicine (1982)|March 8, 2005
A pharmacist model of perceived responsibility for drug therapy outcomesLourdes G Planas, Carole L Kimberlin, Richard Segal, et al.
Journal of Clinical Medicine|April 25, 2020
Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use RegistryJoshua D Brown, Brianna Costales, Sascha van Boemmel-Wegmann, et al.
Pharmacoepidemiology and Drug Safety|July 10, 2019
Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) databaseCaitlin A Knox, Christian Hampp, Kristin Palmsten, et al.
Infectious Agents and Cancer|August 2, 2013
The African cancer advocacy consortium: shaping the path for advocacy in AfricaFolakemi T Odedina, Kwanele Asante-Shongwe, Emmanuel J Kandusi, et al.
Pharmacoepidemiology and Drug Safety|March 8, 2018
Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort studyWei Liu, Patrick J Antonelli, Philipp Dahm, et al.
World Neurosurgery|September 1, 2018
Association Between Recombinant Human Bone Morphogenetic Proteins and Postoperative Opioid Use in Lumbar Fusion Procedure Patients: A Propensity Score-Matched AnalysisIrene B Murimi, Anna Ghambaryan, Robert Decker, et al.
Pageof 5